Implementation of cardiovascular imaging in clinical practice according to 2022 ESC Cardio-Oncology Guidelines: where are we?

Context
The growing population of cancer survivors has brought increasing attention to the cardiovascular complications associated with oncologic therapies. Multimodality cardiovascular imaging—including echocardiography, cardiac magnetic resonance, cardiac computed tomography, and nuclear techniques—has become central to the early detection, risk stratification, and longitudinal surveillance of cancer therapy–related cardiovascular toxicity.

Despite the availability of international recommendations, the use and integration of multimodality imaging in cardio-oncology practice remain variable across Europe. Differences in access, expertise, and local pathways may influence how patients are assessed and followed in routine care.

Objectives
This survey aims to evaluate how cardiovascular imaging is currently accessed and utilised for cardiotoxicity risk stratification and surveillance in cancer patients across Europe. In addition, it seeks to identify practical barriers, regional disparities, and unmet needs, with the goal of informing future initiatives to improve and harmonise cardio-oncology care.

Duration
The survey will take 2 minutes to complete.

Disclaimer

• We will not disclose your identity to any third party.
• We comply with the European General Data Protection Regulation (GDPR) 2016/679. Any personal data processed in connection with this survey will be treated confidentially and only used by the ESC for the purposes of market research and not for promotion. Survey results will be kept for a maximum of 48 months for analysis and quality control purposes. We take all reasonable care to prevent any unauthorised access to your personal data. We respect your privacy and your right to access, modify, or remove your personal data. At any time, you can ask to know what personal data is being held. If you have any questions about data protection or require further information, please contact our data protection officer (DPO) at dpo@escardio.org.
• You have the right to end your participation in this survey at any time.